Can diabetes drugs help PAH patients walk farther?
NCT ID NCT03617458
First seen Oct 31, 2025 · Last updated Jun 15, 2026 · Updated 31 times
Summary
This study looked at whether two treatments that target insulin resistance can help people with pulmonary artery hypertension (PAH). 73 adults with PAH were given one of the treatments or a placebo for 12 weeks. The main goal was to see if they could walk farther in six minutes or improve their daily function. The study aimed to find new ways to manage PAH, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.